A new venture capital firm, built on the foundation of The Longevity Fund, will help advance its mission funding the next generation of companies focused on...
Pharmaceutical company, Cerevance, has secured additional funding to develop its novel therapeutics for central nervous system (CNS) diseases, including Parkinson’s. The drug development company has announced...
Global investment in the longevity sector is demonstrating stronger resilience than the biotech and fintech sectors, according to a new report. Industry analysts at Longevity.Technology have published...
The funding will enable the company to scale up its home care network across the UK.
The funding will further accelerate its leading in-home, technology-enabled system of care.
The acquisition of Hospice Corporation of America by Kain Capital’s PERA Holdings serves as a foundation for the firm’s investment strategy in the hospice and palliative...
